Sanford Burnham Prebys的研究人员在《Science Advances》上发表了一项新研究,发现一种名为SORLA的蛋白质在对抗阿尔茨海默病中起关键保护作用 12。该研究报道时间为2026年11月18日 1。实验表明,在小鼠体内增加SORLA水平能显著减少有毒的Tau蛋白缠结、抑制其过度磷酸化及“种子”扩散作用,从而保护神经元和突触可塑性并防止脑萎缩 12。相反,通过敲除Sorl1基因使小鼠无法产生SORLA蛋白时,则加剧了Tau病理损害和脑萎缩 1。
这一发现揭示了大脑自身的防御机制 1。研究进一步指出,SORLA缺失会导致Plexin-B受体家族上调,而目前已有药物可靶向此类受体 1。这提示通过增强SORLA活性或重新利用针对Plexin-B受体的现有药物(即药物重定位),可能为治疗神经退行性疾病及Tau相关痴呆提供新的潜在策略 1。主要研究人员包括第一作者Huijie Huang博士和资深作者Timothy Huang博士,两人均来自Sanford Burnham Prebys 1。
Researchers at Sanford Burnham Prebys have discovered that a relatively obscure protein known as SORLA plays a critical protective role against the pathology of Alzheimer’s disease. 12 The study, published in Science Advances on November 18, 2026, reveals that elevating SORLA levels in mice significantly reduces toxic tau tangles, protects synaptic connections, and prevents brain shrinkage. 1 Conversely, the absence of this protein exacerbates neuronal damage, highlighting its importance in maintaining brain health. 1 The research was led by first author Dr. Huijie Huang and senior author Dr. Timothy Huang, who identified SORLA as a key component of the brain’s internal defense mechanisms against neurodegeneration. 1
The team demonstrated that increasing SORLA expression not only limits the accumulation of tau tangles but also inhibits their hyperphosphorylation and spread through "seeding" effects, thereby preserving neuron integrity and synaptic plasticity. 1 In control experiments where the Sorl1 gene was knocked out to prevent SORLA production, mice exhibited worsened tau pathology and greater brain atrophy compared to those with normal or elevated SORLA levels. 1 Beyond direct protection, the study uncovered a potential therapeutic avenue: SORLA deficiency triggers an upregulation of Plexin-B receptor family members, which are already targeted by existing drugs. 1 This finding suggests that drug repurposing strategies focusing on Plexin-B receptors could offer new treatments for tau-related dementias. 1
评论
还没有评论,欢迎留下第一条。